(Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
---|---|---|---|---|---|---|---|
Turnover | --180.14M | -6.09%27.47M | 88.82%312.39M | --29.26M | 173.44%165.44M | 14.11%60.5M | --53.02M |
Operating income | 180.14M | -6.09%27.47M | 88.82%312.39M | 29.26M | 173.44%165.44M | 14.11%60.5M | 53.02M |
Cost of sales | ---90.06M | 54.87%-10.74M | -101.39%-235.25M | ---23.79M | -202.37%-116.81M | 5.75%-38.63M | ---40.99M |
Operating expenses | -90.06M | 54.87%-10.74M | -101.39%-235.25M | -23.79M | -202.37%-116.81M | 5.75%-38.63M | -40.99M |
Gross profit | 90.08M | 206.35%16.74M | 58.63%77.14M | 5.46M | 122.34%48.63M | 81.75%21.87M | 12.03M |
Selling expenses | ---51.15M | -2.62%-24.64M | 14.94%-101.84M | ---24.01M | -135.50%-119.73M | -128.43%-50.84M | ---22.26M |
Administrative expenses | ---182.53M | -47.83%-90.3M | -48.20%-318.98M | ---61.08M | -92.69%-215.24M | -241.68%-111.7M | ---32.69M |
Research and development expenses | ---687.33M | -27.35%-339.38M | -78.32%-1.36B | ---266.48M | -28.33%-764.08M | -133.84%-595.38M | ---254.61M |
Impairment and provision | ---13.98M | -194.74%-5.55M | -10.94%-9.41M | ---1.88M | -360.09%-8.48M | -568.12%-1.84M | ---276K |
-Other impairment is provision | ---13.98M | -194.74%-5.55M | -10.94%-9.41M | ---1.88M | -360.09%-8.48M | -568.12%-1.84M | ---276K |
Special items of operating profit | --4.82M | -77.83%3.83M | 208.00%18.72M | --17.29M | -60.11%6.08M | 210.90%15.24M | --4.9M |
Operating profit | -840.1M | -32.84%-439.3M | -61.18%-1.7B | -330.71M | -45.69%-1.05B | -146.73%-722.66M | -292.9M |
Financing income | --19.02M | 80.33%9.64M | 59.11%26.42M | --5.35M | 3,664.63%16.6M | -63.94%441K | --1.22M |
Financing cost | ---3.35M | -54.70%-1.17M | -26.57%-3.38M | ---755K | -11.82%-2.67M | -354.48%-2.39M | ---525K |
Share of profits of associates | ---2.59M | -690.73%-1.96M | -46.00%-1.44M | ---248K | -36.70%-987K | -405.93%-722K | --236K |
Special items of earning before tax | --1.93B | 309.67%1.64B | -85.51%-3.18B | ---780.3M | -5.08%-1.71B | -248.34%-1.63B | ---468.28M |
Earning before tax | 1.1B | 208.73%1.2B | -76.30%-4.86B | -1.11B | -16.87%-2.75B | -209.97%-2.36B | -760.24M |
After-tax profit from continuing operations | 1.1B | 208.73%1.2B | -76.30%-4.86B | -1.11B | -16.87%-2.75B | -209.97%-2.36B | -760.24M |
Earning after tax | 1.1B | 208.73%1.2B | -76.30%-4.86B | -1.11B | -16.87%-2.75B | -209.97%-2.36B | -760.24M |
Profit attributable to shareholders | 1.1B | 208.73%1.2B | -76.30%-4.86B | -1.11B | -16.87%-2.75B | -209.97%-2.36B | -760.24M |
Basic earnings per share | 15.1 | 208.33%16.9 | -76.29%-68.4 | -15.6 | -20.87%-38.8 | -237.89%-32.1 | -9.5 |
Diluted earnings per share | -1.7 | 94.23%-0.9 | -76.29%-68.4 | -15.6 | -20.87%-38.8 | -237.89%-32.1 | -9.5 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | PricewaterhouseCoopers | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data